News Eli Lilly and Company Xetra

Equities

LLY

US5324571083

Real-time Estimate Tradegate Other stock markets 10:35:39 2024-07-17 am EDT			5-day change	1st Jan Change
831.4 ^EUR	-4.68%		-3.91%	+58.35%

03:53pm	TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	MT
03:38pm	Earnings reports take center stage as tech stocks tumble

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	09:53am	MT
Earnings reports take center stage as tech stocks tumble	09:38am
Wall Street set to fall as megacap chip, tech stocks tumble	09:14am	RE
ANALYST RECOMMENDATIONS : American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...	05:11am
Roche reports positive early results in obesity drug trial	02:13am	RE
Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly	Jul. 16	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793	Jul. 16	MT
Novo owner backs Swiss biotech Asceneuron in $100 million round	Jul. 16	RE
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market	Jul. 12	RE
Ozempic linked with lower dementia risk, nicotine use, British study finds	Jul. 12	RE
EU Drug Regulator Issues New Safety Measures for GLP-1 Drugs Amid Aspiration Risk Concerns	Jul. 12	MT
UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating	Jul. 12	MT
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says	Jul. 12	RE
Neuroendocrine Tumors Pipeline 2024 \| Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene	Jul. 12	AQ
Health Care Up as Obesity-Drug Wars Continue -- Health Care Roundup	Jul. 11	DJ
Pfizer moves forward with once-daily weight loss drug	Jul. 11	RE
JPMorgan Adjusts Price Target on Eli Lilly and Co. to $1,000 From $900, Maintains Overweight Rating	Jul. 11	MT
Morgan Stanley Adjusts Price Target on Eli Lilly and Co. to $1,083 From $1,023, Maintains Overweight Rating	Jul. 11	MT
Berenberg Adjusts Price Target on Eli Lilly & Co. to $1,000 From $850, Maintains Buy Rating	Jul. 11	MT
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices	Jul. 10	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT